Care este prețul pentru Formosa Pharmaceuticals, Inc. (6838)

Prețul pentru Formosa Pharmaceuticals, Inc. (6838) este $0.79338575

Care este capitalizarea de piață pentru Formosa Pharmaceuticals, Inc. (6838)

Capitalizarea de piață pentru Formosa Pharmaceuticals, Inc. (6838) este $119.78M

Formosa Pharmaceuticals, Inc. (6838) Raport P/B

Formosa Pharmaceuticals, Inc., a biopharmaceutical firm situated in Taipei City, Taiwan, is actively engaged in both late-preclinical and early clinical development stages. Its core focus lies in pioneering therapeutic candidates across ophthalmology, oncology, and anti-infective domains. Among its key investigational assets is APP13007, an ophthalmic nanosuspension, currently progressing through Phase III trials for managing post-surgical discomfort and inflammation of the eye. The company's portfolio also encompasses TSY-0110, designed as an antibody-drug conjugate, and TSY-0210, an antibiotic targeting resilient drug-resistant infections. Further compounds under development include APP13002, a topical antibiotic intended for ocular infections like blepharitis, and MPT0E028, a novel pan-histone deacetylase inhibitor being explored for solid malignancies such as hepatomas and colorectal cancer, in addition to lung fibrosis. Additionally, Formosa Pharmaceuticals maintains a collaborative partnership with Eyenovia, Inc., dedicated to advancing innovative ophthalmic treatments. Established in 2010, the company is headquartered in Taiwan's capital.

An	Raport P/B	Schimbă
Nu sunt suficiente date pentru perioada selectată.

Raport P/B

Schimbă

Nu sunt suficiente date pentru perioada selectată.

Companie	Raport P/B	Diferență raport P/B	Țara
Vertex Pharmaceuticals Incorporated VRTX.US	6.3419	-	US
Argenx SE ARGX.US	6.2413	-	NL
Moderna, Inc. MRNA.US	3.7087	-	US
CSL Limited CSL.AX	2.5054	-	AU
Lonza Group AG LONN.SW	-	-	CH

Companie

Raport P/B

Diferență raport P/B

Țara